179 related articles for article (PubMed ID: 17898548)
1. [The role of activated hepatic stellate cells in liver fibrosis, portal hypertension and cancer angiogenesis].
Lee JS; Kim JH
Korean J Hepatol; 2007 Sep; 13(3):309-19. PubMed ID: 17898548
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatic stellate cells in the pathogenesis of portal hypertension.
Marra F; Pinzani M
Nefrologia; 2002; 22 Suppl 5():34-40. PubMed ID: 12107915
[No Abstract] [Full Text] [Related]
3. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
Iwakiri Y; Shah V; Rockey DC
J Hepatol; 2014 Oct; 61(4):912-24. PubMed ID: 24911462
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?
Lee JS; Semela D; Iredale J; Shah VH
Hepatology; 2007 Mar; 45(3):817-25. PubMed ID: 17326208
[No Abstract] [Full Text] [Related]
5. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?
Thabut D; Shah V
J Hepatol; 2010 Nov; 53(5):976-80. PubMed ID: 20800926
[TBL] [Abstract][Full Text] [Related]
6. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis].
Garbuzenko DV
Ter Arkh; 2014; 86(2):90-5. PubMed ID: 24772515
[TBL] [Abstract][Full Text] [Related]
7. Role of Kupffer cells in the pathogenesis of liver disease.
Kolios G; Valatas V; Kouroumalis E
World J Gastroenterol; 2006 Dec; 12(46):7413-20. PubMed ID: 17167827
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stellate cells--the pericytes in the liver.
Hellerbrand C
Pflugers Arch; 2013 Jun; 465(6):775-8. PubMed ID: 23292551
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic therapies in portal hypertension: a breakthrough in hepatology.
Rosmorduc O
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):446-9. PubMed ID: 20630674
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and a Rational Basis of Therapy.
Gracia-Sancho J; Maeso-Díaz R; Bosch J
Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease.
Rosmorduc O; Housset C
Semin Liver Dis; 2010 Aug; 30(3):258-70. PubMed ID: 20665378
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma.
Li H
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):217-233. PubMed ID: 33131349
[No Abstract] [Full Text] [Related]
13. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
14. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
Coch L; Mejias M; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Mendez R; Fernandez M
Hepatology; 2014 Aug; 60(2):633-47. PubMed ID: 24390792
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.
Reynaert H; Thompson MG; Thomas T; Geerts A
Gut; 2002 Apr; 50(4):571-81. PubMed ID: 11889082
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives.
Garbuzenko DV; Arefyev NO; Kazachkov EL
World J Gastroenterol; 2018 Sep; 24(33):3738-3748. PubMed ID: 30197479
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
[TBL] [Abstract][Full Text] [Related]
18. Liver cirrhosis and hepatic stellate cells.
Brandão DF; Ramalho LN; Ramalho FS; Zucoloto S; Martinelli Ade L; Silva Ode C
Acta Cir Bras; 2006; 21 Suppl 1():54-7. PubMed ID: 17013515
[TBL] [Abstract][Full Text] [Related]
19. Liver cirrhosis.
Pinzani M; Rosselli M; Zuckermann M
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):281-90. PubMed ID: 21497745
[TBL] [Abstract][Full Text] [Related]
20. Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.
Uschner FE; Ranabhat G; Choi SS; Granzow M; Klein S; Schierwagen R; Raskopf E; Gautsch S; van der Ven PF; Fürst DO; Strassburg CP; Sauerbruch T; Diehl AM; Trebicka J
Sci Rep; 2015 Sep; 5():14573. PubMed ID: 26412302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
